The Evolution of Transcatheter Aortic Valve Replacement: From Novel to Normal

Over the past decade, transcatheter aortic valve replacement (TAVR) has become a transformative intervention for patients with aortic stenosis (AS). With a minimally invasive approach, TAVR reduces overall risks to the patient compared to the traditional surgical aortic valve replacement. Improvements in technology, training, and access to registered TAVR-designated sites, as well as the high success rate of the procedure, have turned TAVR from a novel approach into the preferred, first-line treatment for patients with AS. The purpose of this review article is to educate RNs and advanced practice RNs (APRNs, including NPs, clinical nurse specialists, anesthetists, and midwives) on the current evidence-based approaches to evaluation, diagnosis, and management of AS before and after TAVR, as well as the evolving role of TAVR in the treatment of AS. Given that TAVR has become the mainstay of treatment for AS, there is a need for RNs and APRNs to be experts in the evidence-based practice guidelines for evaluation, diagnosis, and treatment of this potentially deadly disease.